Contact
searchSearch
HMP Global
Login
Non-Small Cell Lung Cancer
Excellence Forum

Non-Small Cell Lung Cancer Excellence Forum

Sledge
Interview
Reevaluating Tissue-Agnostic Therapies: Insights From a Real-World Genomic Analysis
07/25/2025
George W. Sledge, MD
In this interview, George W. Sledge, MD, explores the promise and limitations of tissue-agnostic cancer therapies, highlighting real-world disparities, biomarker variability, and the urgent need for better clinical decision support to guide...
In this interview, George W. Sledge, MD, explores the promise and limitations of tissue-agnostic cancer therapies, highlighting real-world disparities, biomarker variability, and the urgent need for better clinical decision support to guide...
In this interview, George W....
07/25/2025
Journal of Clinical Pathways
Upal Basu Roy, PhD, MPH
Interview
Project PRIORITY: Elevating the Patient Voice in EGFR-Positive NSCLC Care
03/24/2025
Upal Basu Roy, PhD, MPH
In this interview, Upal Basu Roy, PhD, MPH, shares how by centering on patient experiences, Project PRIORITY reveals critical disparities in access to diagnostics, treatment, and palliative care for patients with epidermal growth factor...
In this interview, Upal Basu Roy, PhD, MPH, shares how by centering on patient experiences, Project PRIORITY reveals critical disparities in access to diagnostics, treatment, and palliative care for patients with epidermal growth factor...
In this interview, Upal Basu...
03/24/2025
Journal of Clinical Pathways
Interview
Strategies to Expand Access to Genomic Testing for Patients With NSCLC
03/07/2025
Anne S. Tsao, MD, MBA, FASCO, FACHE
In this interview, Anne S. Tsao, MD, MBA, FASCO, FACHE, discusses the challenges of managing resistance to EGFR-targeted therapies in non-small cell lung cancer and highlights emerging strategies to overcome treatment resistance.
In this interview, Anne S. Tsao, MD, MBA, FASCO, FACHE, discusses the challenges of managing resistance to EGFR-targeted therapies in non-small cell lung cancer and highlights emerging strategies to overcome treatment resistance.
In this interview, Anne S. Tsao,...
03/07/2025
Journal of Clinical Pathways
Zou
Interview
Leveraging Machine Learning and Real-World Data for Precision Oncology Care
02/14/2025
In an interview with guest expert James Zou, PhD, associate professor of Biomedical Data Science at Stanford University, learn about the potential for using machine learning and real-world data to identify mutations that predict patient...
In an interview with guest expert James Zou, PhD, associate professor of Biomedical Data Science at Stanford University, learn about the potential for using machine learning and real-world data to identify mutations that predict patient...
In an interview with guest...
02/14/2025
Journal of Clinical Pathways
von Itzstein Headshot
Interview

Selinexor and Docetaxel Indicate Promise in KRAS-Mutant NSCLC
01/24/2025
Mitchell von Itzstein, MD
In this interview, Mitchell von Itzstein, MD, discusses the challenges of treating KRAS-mutant non-small cell lung cancer (NSCLC), the potential of selinexor in combination with docetaxel, and the need for further research to refine treatment...
In this interview, Mitchell von Itzstein, MD, discusses the challenges of treating KRAS-mutant non-small cell lung cancer (NSCLC), the potential of selinexor in combination with docetaxel, and the need for further research to refine treatment...
In this interview, Mitchell von...
01/24/2025
Journal of Clinical Pathways
Patel Headshot
Interview
Evolving Clinical Pathways for Perioperative Strategies in Resectable NSCLC
01/09/2025
Sandip Patel, MD
In this interview, Sandip Patel, MD, discusses the evolution of clinical pathways for non-small cell lung cancer (NSCLC), including the integration of perioperative strategies, the potential of immunotherapy in earlier stages, the role of...
In this interview, Sandip Patel, MD, discusses the evolution of clinical pathways for non-small cell lung cancer (NSCLC), including the integration of perioperative strategies, the potential of immunotherapy in earlier stages, the role of...
In this interview, Sandip Patel,...
01/09/2025
Journal of Clinical Pathways
Shaverdian Headshot
Interview
Incorporating Precision Medicine and AI Into NSCLC Radiation Approaches
12/19/2024
Narek Shaverdian, MD
In this interview, Narek Shaverdian, MD, discusses the evolving role of radiation therapy in NSCLC treatment, highlighting advancements in precision medicine, the integration of AI, and promising research aimed at improving patient outcomes.
In this interview, Narek Shaverdian, MD, discusses the evolving role of radiation therapy in NSCLC treatment, highlighting advancements in precision medicine, the integration of AI, and promising research aimed at improving patient outcomes.
In this interview, Narek...
12/19/2024
Journal of Clinical Pathways
Johnetta Blakely
Interview
Treatment Patterns and Outcomes for Patients With NSCLC, Implications for Clinical Pathways
12/13/2024
L. Johnetta Blakely, MD, MS
Explore the real-world value of clinical pathways for patients with NSCLC, the challenges hindering progress in research, key findings from a retrospective study, and potential implications for treatment with immunotherapy.
Explore the real-world value of clinical pathways for patients with NSCLC, the challenges hindering progress in research, key findings from a retrospective study, and potential implications for treatment with immunotherapy.
Explore the real-world value of...
12/13/2024
Journal of Clinical Pathways
Rodriguez Headshot
Interview
Balancing Novel Therapies and Equitable Access in NSCLC Treatment Pathways
12/12/2024
Estelamari Rodriguez, MD, MPH
In this interview, Estelamari Rodriguez, MD, MPH, discusses the challenges and advancements in non-small cell lung cancer (NSCLC) care, including strategies for managing uncommon EGFR mutations, the potential of antibody-drug conjugates,...
In this interview, Estelamari Rodriguez, MD, MPH, discusses the challenges and advancements in non-small cell lung cancer (NSCLC) care, including strategies for managing uncommon EGFR mutations, the potential of antibody-drug conjugates,...
In this interview, Estelamari...
12/12/2024
Journal of Clinical Pathways
Interview
Streamlining NSCLC Treatment Through Collaboration and Pathway-Guided Decisions
11/27/2024
Sonam Puri, MD
In this interview, Sonam Puri, MD, Moffitt Cancer Center, discusses the critical role of multidisciplinary teams, pathway-guided decision-making, and patient-centered strategies in optimizing care for non-small cell lung cancer while...
In this interview, Sonam Puri, MD, Moffitt Cancer Center, discusses the critical role of multidisciplinary teams, pathway-guided decision-making, and patient-centered strategies in optimizing care for non-small cell lung cancer while...
In this interview, Sonam Puri,...
11/27/2024
Journal of Clinical Pathways
JCP Nov-Dec Cover

Current Issue

December 2025
Volume 11
Issue 6
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use